Clinical Trial Update: Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis

View source ↗

Summary

A completed clinical trial evaluated serum procalcitonin as a biomarker in critically ill patients with suspected sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Aga Khan University | Conditions: Sepsis | Status: COMPLETED